India Ratings upgrades Strides Arcolab’s long-term rating to ‘BBB+’

27 Oct 2012 Evaluate

Credit rating agency, India Ratings & Research (India Ratings), a Fitch Group Company, has upgraded Strides Arcolab’s long-term issuer rating to ‘BBB+’ from ‘BBB-’ with stable outlook.

The upgrade reflects the agency’s expectation of a sustained improvement in the company’s financial leverage (adjusted debt / EBITDA) in the medium term.

Strides Arcolab is a global pharmaceutical company headquartered in Bangalore, India that develops and manufactures wide range of IP-lead niche pharmaceutical products with an emphasis on sterile injectables.

Strides Pharma Scien Share Price

902.10 -11.45 (-1.25%)
02-Jan-2026 11:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1728.70
Dr. Reddys Lab 1248.85
Cipla 1508.50
Zydus Lifesciences 917.40
Lupin 2108.80
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×